![Cyrus Harmon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cyrus Harmon
Founder at
OLEMA PHARMACEUTICALS, INC.
Net worth: 11 M $ as of 2026-05-30
Profile
Cyrus L.
Harmon was the founder of Neomorphics, Inc., founded in 1996, where the title held was Chief Executive Officer from 1996 to 2000.
Dr. Harmon is the founder of Olema Pharmaceuticals, Inc., founded in 2006, holding the title of Independent Director.
Dr. Harmon currently works at Vilya, Inc. as President & Chief Executive Officer since 2023.
Formerly, Dr. Harmon was General Manager at Affymetrix, Inc. from 2000 to 2002.
Education includes undergraduate and doctorate degrees from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-17 | 844,798 ( 0.97% ) | 11 M $ | 2026-05-30 |
Cyrus Harmon active positions
| Companies | Position | Start |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Founder | 2006-08-06 |
Vilya Inc.
 Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Chief Executive Officer | 2023-09-30 |
Former positions of Cyrus Harmon
| Companies | Position | End |
|---|---|---|
| AFFYMETRIX, INC. | Corporate Officer/Principal | 2001-12-31 |
Neomorphics, Inc.
 Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Chief Executive Officer | 1999-12-31 |
Training of Cyrus Harmon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
19
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Vilya Inc.
Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Health Technology |
- Stock Market
- Insiders
- Cyrus Harmon
